MEA Traceability

Lebanon's Ministry of Public Health (MoPH) has implemented the MediTrack system as a comprehensive pharmaceutical traceability solution designed to safeguard public health and ensure medicine authenticity throughout the supply chain. This GS1-compliant track and trace system represents Lebanon's commitment to combating counterfeit medicines, preventing diversion, and maintaining transparent pharmaceutical distribution from manufacturing to patient dispensing.

Libya has established a robust regulatory framework that encompasses both pharmaceutical product serialization and comprehensive cargo tracking systems. Through the Ministry of Economy and Commerce's Decision No. 379 of 2023 and the implementation of the Advance Cargo Information (ACI) system, Libya demonstrates its commitment to enhancing product safety, combating counterfeiting, and strengthening customs oversight across all imported goods.

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) stands at the forefront of pharmaceutical safety through its ambitious track and trace regulations. Established under Nigeria's commitment to combating substandard and falsified medicines, NAFDAC's traceability framework represents a transformative approach to pharmaceutical supply chain integrity. This comprehensive system aims to provide end-to-end visibility from manufacturing facilities to patients, fundamentally reshaping how pharmaceutical products are monitored and protected throughout Nigeria's healthcare ecosystem.

In the Sultanate of Oman, pharmaceutical safety and quality are overseen by the Ministry of Health through specialized directorates that maintain rigorous standards for drug registration, distribution, and compliance. Oman's pharmaceutical regulatory system emphasizes patient safety while aligning with international best practices, creating a robust framework that governs every aspect of the pharmaceutical supply chain from registration to retail distribution.

Qatar is at the forefront of pharmaceutical supply chain innovation through a comprehensive track and trace system developed jointly by the Ministry of Public Health (MoPH) and the GS1 Qatar Office under the Qatar Development Bank (QDB). This groundbreaking initiative represents Qatar's commitment to establishing a world-class pharmaceutical regulatory framework that ensures drug authenticity, patient safety, and supply chain transparency from manufacturers to end consumers.

Rwanda's pharmaceutical landscape has been revolutionized through the implementation of comprehensive track and trace regulations by the Rwanda Food and Drugs Authority (Rwanda FDA). Established in August 2022, these regulations represent a forward-thinking approach to pharmaceutical security, designed to protect public health while enhancing supply chain transparency and efficiency across the entire pharmaceutical ecosystem.